Nobel Prizewinning health researcher Peter Doherty reflects on the challenge of delivering a healthy climate for the world. From hydrogen power to wooden skyscrapers, the options are endless, but all require leadership.
Academic rigor, journalistic flair
The Peter Doherty Institute for Infection and Immunity
The Doherty Institute is a world-class institute combining research, teaching, public health and reference laboratory services, diagnostic services and clinical care into infectious diseases and immunity. The establishment of the Doherty Institute represents a radical change in the capacity of Australia and the world to detect, investigate and respond to existing, emerging and re-emerging infectious diseases and agents, with a major focus on diseases that pose serious public and global health threats such as influenza, tuberculosis, HIV, viral hepatitis and drug resistant bacteria. The Doherty’s activities are multi-disciplinary and cross-sectoral, placing great emphasis on translational research and improving clinical outcomes. Teams of interdisciplinary scientists, clinicians and epidemiologists collaborate on a wide spectrum of activities - from basic immunology and discovery research, to the development of new vaccines and new preventative and treatment methods, to surveillance and investigation of disease outbreaks.
Links
Displaying 1 - 20 of 28 articles
Born in Italy in 1909, Levi-Montalcini avoided being transported to Auschwitz as a young woman and rose to prominence as a neurobiologist. She was a co-recipient of the 1986 Nobel Prize for Medicine.
Nobel laureate Peter Doherty explains immunity.
While not perfect, the seasonal flu vaccine is the best way to protect against influenza. There are a few changes to the flu vaccine and what is available this year. Here's what you need to know.
Hepatitis A is a virus that infects the liver. Symptoms usually take 15-50 days to develop after initial infection and typically last for several weeks or sometimes longer.
Scientific problems require evidence-led solutions. A new proposal to create a federal environmental decision-making body would take some of the politics out of climate policy.
We know overuse and inappropriate use of antibiotics contribute to resistance, so it's important we develop strategies to improve practice.
Why is it the flu virus is so deadly compared to the common cold virus?
Hepatitis B rates in Indigenous communities are ten times higher than the rest of Australia. Eliminating the infection from Indigenous Australia can make a significant contribution to closing the gap.
Why is it only some viruses are transmissible by blood, and how does the virus actually move from person to person?
Here we explore our past and present struggles with the most significant infectious diseases human beings have faced.
Professor Peter Doherty on infectious disease pandemics.
The Conversation, CC BY-ND47.6 MB (download)
William Isdale speaks with the University of Melbourne's Professor Peter Doherty about infectious disease pandemics.
In its broadest sense, the March for Science aims to cause US legislators to reflect a little and understand what they risk if they choose to erode their global scientific leadership.
HIV diagnosis is devastating for patients and their families. But the infection is no longer a death sentence, and should not be prosecuted as such say experts.
Peter Doherty's Nobel Prize-winning insights proved crucial for understanding how viral infections are controlled.
Hepatitis A, B, C, D and E are very different viruses. Hepatitis A is genetically closer to the common cold than it is to hepatitis B. Hepatitis C is closer to the virus that causes dengue fever.
Efficacy is estimated to be as high as 99% in men who have sex with men who take Truvada daily.
As the new Australian parliament takes the reins, health groups are moving to ensure the new health minister addresses a major health threat in this term of government: climate change.
HIV research continues to search for a cure. The focus is on developing therapies to cure HIV infection or allow people with HIV to safely stop antiretroviral therapy and keep the virus under control.
There are several areas where Australia could be a world leader in innovation. If we can identify them and focus our efforts there, we could generate some genuine benefits here and abroad.
Research and Expert Database
Authors
-
Director, WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity
-
Advanced Trainee, Infectious Diseases and General Medicine, The Peter Doherty Institute for Infection and Immunity
-
University of Melbourne Associate Professor, Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity
-
Professor, The Peter Doherty Institute for Infection and Immunity
-
Professor, The Peter Doherty Institute for Infection and Immunity
-
Associate Professor, The Peter Doherty Institute for Infection and Immunity
-
Epidemiologist, WHO Collaboating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity
-
Peter C. Doherty is a Friend of The Conversation.
Laureate Professor, The Peter Doherty Institute for Infection and Immunity
-
Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital and Monash University, The Peter Doherty Institute for Infection and Immunity
-
Associate Professor, The Peter Doherty Institute for Infection and Immunity
-
Clinical Research Fellow, The Peter Doherty Institute for Infection and Immunity
-
Infectious diseases and general physician, The Peter Doherty Institute for Infection and Immunity
